|
XB-GENEPAGE-1005778
Papers associated with drd2
???pagination.result.count???
???pagination.result.page??? 1
| Sort Newest To Oldest | Sort Oldest To Newest |
referenced by: |
Functional expression and characterization of human D2 and D3 dopamine receptors., Potenza MN, Graminski GF, Schmauss C, Lerner MR., J Neurosci. March 1, 1994; 14 (3 Pt 2): 1463-76. |
|
The thrombin receptor second cytoplasmic loop confers coupling to Gq-like G proteins in chimeric receptors. Additional evidence for a common transmembrane signaling and G protein coupling mechanism in G protein-coupled receptors., Verrall S, Ishii M, Chen M, Wang L, Tram T, Coughlin SR., J Biol Chem. March 14, 1997; 272 (11): 6898-902. |
|
Genomic analysis and functional expression of canine dopamine D2 receptor., Myeong H, Jeoung D, Kim H, Ha JH, Lee Y, Kim KH, Park C, Kaang BK., Gene. October 17, 2000; 257 (1): 99-107. |
|
Dopamine D2 receptor regulation of the dopamine transporter expressed in Xenopus laevis oocytes is voltage-independent., Mayfield RD, Zahniser NR., Mol Pharmacol. January 1, 2001; 59 (1): 113-21. |
|
RGS9-2 mediates specific inhibition of agonist-induced internalization of D2-dopamine receptors., Celver J, Sharma M, Kovoor A., J Neurochem. August 1, 2010; 114 (3): 739-49. |
|
Arrestin-dependent but G-protein coupled receptor kinase-independent uncoupling of D2-dopamine receptors., Celver J, Sharma M, Thanawala V, Christopher Octeau J, Kovoor A., J Neurochem. October 1, 2013; 127 (1): 57-65. |
|
Typical and atypical antipsychotics do not differ markedly in their reversibility of antagonism of the dopamine D2 receptor., Sahlholm K, Marcellino D, Nilsson J, Ögren SO, Fuxe K, Århem P., Int J Neuropsychopharmacol. January 1, 2014; 17 (1): 149-55. |
|
RGS4 regulates partial agonism of the M2 muscarinic receptor-activated K+ currents., Chen IS, Furutani K, Inanobe A, Kurachi Y., J Physiol. March 15, 2014; 592 (6): 1237-48.  |
|
Targeted deletion of the aquaglyceroporin AQP9 is protective in a mouse model of Parkinson's disease., Stahl K, Rahmani S, Prydz A, Skauli N, MacAulay N, Mylonakou MN, Torp R, Skare Ø, Berg T, Leergaard TB, Paulsen RE, Ottersen OP, Amiry-Moghaddam M., PLoS One. January 1, 2018; 13 (3): e0194896.  |
|
The Beta-Arrestin-Biased Dopamine D2 Receptor Ligand, UNC9994, Is a Partial Agonist at G-Protein-Mediated Potassium Channel Activation., Ågren R, Århem P, Nilsson J, Sahlholm K., Int J Neuropsychopharmacol. December 1, 2018; 21 (12): 1102-1108.  |
|
Ligand with Two Modes of Interaction with the Dopamine D2 Receptor-An Induced-Fit Mechanism of Insurmountable Antagonism., Ågren R, Zeberg H, Stępniewski TM, Free RB, Reilly SW, Luedtke RR, Århem P, Ciruela F, Sibley DR, Mach RH, Selent J, Nilsson J, Sahlholm K., ACS Chem Neurosci. October 7, 2020; 11 (19): 3130-3143.  |
|
Dopamine D2 Receptor Agonist Binding Kinetics-Role of a Conserved Serine Residue., Ågren R, Stepniewski TM, Zeberg H, Selent J, Sahlholm K., Int J Mol Sci. April 15, 2021; 22 (8):  |
|
Dopamine-induced arrestin recruitment and desensitization of the dopamine D4 receptor is regulated by G protein-coupled receptor kinase-2., Burström V, Ågren R, Betari N, Valle-León M, Garro-Martínez E, Ciruela F, Sahlholm K., Front Pharmacol. January 1, 2023; 14 1087171.  |
???pagination.result.page??? 1